In vitro assessment of a chemically synthesized Shiga toxin receptor analog attached to Chromosorb P (Synsorb Pk) as a specific absorbing agent of Shiga toxin 1 and 2

Microbiology and Immunology

Volumn 43, Issue 4, 1999, Pages 331-337

  Takeda, Tae ^a   Yoshino, Ken Ichi ^a   Adachi, Eriko ^a   Sato, Yuko ^a   Yamagata, Kyoko ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

Gb3; HUS; O157:H7; Shiga toxin adsorbent; Synsorb Pk

Indexed keywords

CHROMOSORB P; RECEPTOR; SHIGA TOXIN; SORBENT; SYNSORB PK; TRISACCHARIDE; UNCLASSIFIED DRUG;

ABSORPTION; ARTICLE; BACTERIAL INFECTION; CARCINOMA CELL; CONTROLLED STUDY; CYTOTOXICITY; ESCHERICHIA COLI; FETAL CALF SERUM; HEAT TREATMENT; HEMOLYTIC UREMIC SYNDROME; HEMORRHAGIC COLITIS; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY CARCINOMA;

BACTERIA (MICROORGANISMS); CICONIIFORMES; ESCHERICHIA COLI; NEGIBACTERIA;

EID: 0032910242     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.1999.tb02413.x     Document Type: Article

References (31)

1. Armstrong, G.D., Fodor, E., and Vanmaele, R. 1991. Investigation of Shiga-like toxin binding to chemically synthesized oligosaccharide sequences. J. Infect. Dis. 164: 1160-1167.
2. Armstrong, G.D., Rowe, P.C., Goodyer, P., Orrbine, E., Klassen, T.P., Wells, G., MacKenzie, A., Lior, H., Blanchard, C., Auchlair, F., Thompson, B., Rafter, D.J., and McLaine, P.N. 1995. A phase I study of chemically synthesized verotoxin (Shiga-like toxin) Pk-trisaccharide receptors attached to Chromosorb for preventing hemolytic uremic syndrome. J. Infect. Dis. 171: 1042-1045.
3. Armstrong, G.D., McLaine, P.N., and Rowe, C. 1998. Clinical trials of Synsorb Pk in preventing hemolytic uremic syndrome, p. 374-384. In Kaper, J.B., and O'Brien, A.D. (eds), Escherichia coli O157:H7 and other Shiga toxin-producing E. coli strains. ASM Press, Washington, D.C.
4. Bell, B.P., Griffin, P., Lozano, P., Christie, D., Kobayashi, J., and Tarr, P. 1997. Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections. Pediatrics 100: 127.
5. Boyd, B., and Lingwood, C. 1989. Verotoxin receptor glycolipid in human renal tissue. Nephron 51: 207-210.
6. Cimoli, N., Morrison, B.J., and Carter, J.E. 1992. Risk factors for the central nervous system manifestations of gastroenteritis associated hemolytic uremic syndrome. Pediatrics 90: 616-621.
7. Fujii, J., Kita, T., Yoshida, S., Takeda, T., Kobayashi, H., Tanaka, N., Ohsato, K., and Mizuguchi, Y. 1994. Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H in mitomycin-treated mice. Infect. Immun. 62: 3447-3453.
8. Hataya, H. 1997. Task force on the mass outbreak of diarrhea in school children in Sakai City. In Sakai City (eds), Report on the outbreak of E. coli O157 infection in Sakai City, Sakai City, Osaka.
9. Ito, H., Yutsudo, T., Hirayama, T., and Takeda, Y. 1988. Isolation and some properties of A and B subunits of Verotoxin 2 and in vitro formation of hybrid toxins between subunits of Verotoxin 1 and Verotoxin 2 from Escherichia coli O157:H7. Microb. Pathogen. 5: 189-195.
10. Johnson, W.M., Lior, H., and Bezanson, G.S. 1983. Cytotoxic Escherichia coli O157:H7 associated with hemorrhagic colitis in Canada. Lancet i: 76.
11. Karmali, M.A., Steele, B.T., Petric, M., and Lim, C. 1983. Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet i: 619-620.
12. Karmali, M.A., Petric, M., Lim, C., Fleming, P.C., Arbus, G.S., and Lior, H. 1985. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J. Infect. Dis. 151: 775-782.
13. Kurazono, H., Sasakawa, C., Yoshikawa, M., and Takeda, Y. 1987. Cloning of a Vero toxin (VT1, Shiga-like toxin I) gene from a VT-converting phage isolated from Escherichia coli O157:H7. FEMS Microbiol. Lett. 44: 23-26.
14. Lingwood, C.A., Law, H., Richardson, S., Petric, M., Brunton, J.L., Grandis, S.D., and Karmali, M. 1987. Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. J. Biol. Chem., 262: 8834-8839.
15. Louis, C.B., and Obring, T.G. 1992. Shiga-toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of Shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro. Infect. Immun. 60: 1536-1543.
16. Noda, M., Yutsudo, T., Nakabayashi, N., Hirayama, T., and Takeda, Y. 1987. Purification and some properties of Shiga-like toxin from Escherichia coli O157:H7 that is immunologically identical to Shiga toxin. Microb. Pathog. 2: 339-349.
17. O'Brien, A.D., Lively, T.A., Chen, M., Rothman, S.W., and Formal, S.B. 1983. Escherichia coli O157:H7 strains associated with haemorrhagic colitis in the United States produce a Shigella dysenteriae 1 (Shiga) like cytotoxin. Lancet i: 702.
18. Richardson, S.E., Rotman, T.A., Jay, V., Smith, C.R., Becker, L.E., Petric, M., Olivieri, N.F., and Karmali, M.A. 1992. Experimental verocytotoxemia in rabbits. Infect. Immun. 60: 4154-4167.
19. Riddell, R.J., Clothier, R.H., and Balls, M. 1986. An evaluation of these in vitro cytotoxicity assays. Food. Chem. Toxicol. 24: 469-471.
20. Riley, L.W., Remis, R.S., Helgerson, S.D., McGee, H.B., Wells, J.G., Davis, B.R., Hebert, R.J., Olcott, E.S., Johnson, L.M., Hargrett, N.T., Blake, P.A., and Cohen, M.L. 1983. Hemorrhagic colitis associated with a rare Escherichia coli serotype. New Engl. J. Med. 308: 681-685.
21. Riley, L.W. 1987. The epidemiologic, clinical, and microbiologic features of hemorrhagic colitis. Annu. Rev. Microbiol. 44: 383-407.
22. Robson, W.L.M., Leung, A.K.C., and Montgomery, M.D. 1991. Causes of death in hemolytic uremic syndrome. Child Nephrol. Urol. 11: 228-233.
23. Siegler, R.L. 1994. Spectrum of extrarenal involvement in postdiarrheal hemolytic-uremic syndrome. J. Pediatr. 125: 511-518.
24. Taguchi, T., Uchida, H., Kiyotaka, N., Mori, T., Sato, N., Horie, H., Takeda, T., and Fujimoto, J. 1998. Verotoxins induce apoptosis in human renal tubular epithelium derived cells. Kidney Int. 53: 1681-1688.
25. Takeda, T., Dohi, S., Igarashi, T., Yamanaka, T., Yoshiya, K., and Kobayashi, N. 1993. Impairment by Verotoxin of tubular function contributes to the renal damage seen in haemolytic uremic syndrome. J. Infect. 27: 339-341.
26. Takeda, T., Yoshino, K., Adachi, E., Yamagata, K., Uchida, H., Okonogi, K., and Iizawa, Y. 1998. In vitro specific binding of Shiga toxin 1 and 2 by TAK-75IS. J. Jpn. Assoc. Infect. Dis. 72: 924-934.
27. Waddell, T., Head, S., Petric, M., Cohen, A., and Lingwood, C. 1988. Globotriosyl-ceramide is specifically recognized by the Escherichia coli verocytotoxin 2. Biochem. Biophys. Res. Commun. 152: 674-679.
28. Waddell, T., Cohen, A., and Lingwood, C.A. 1990. Indication of verotoxin sensitivity in receptor deficient cell lines using the receptor glycolipid globotriosylceramide. Proc. Natl. Acad. Sci. U.S.A. 87: 7898-7901.
29. Yamasaki, S., Zaw, L., Shirai, H., Terai, A., Oku, Y., Ito, H., Ohmura, M., Karasawa, T., Tsukamoto, T., Kurazono, H., and Takeda, Y. 1996. Typing of verotoxins by DNA colony hybridization with poly-and oligonucleotide probes, a bead-enzyme-linked immunosorbent assay and polymerase chain reaction. Microbiol. Immunol. 40: 345-352.
30. Yutsudo, T., Nakabayashi, N., Hirayama, T., and Takeda, Y. 1987. Purification and some properties of a Vero toxin from Escherichia coli O157:H7 that is immunologically unrelated to Shiga toxin. Microb. Pathog. 3: 21-30.
31. Yutsudo, T., Kurazono, H., Sasakawa, C., Yoshikawa, M., and Takeda, Y. 1987. Cloning of a Vero toxin (VT2) gene from a VT-converting phage isolated from Escherichia coli O157:H7. FEMS Microbiol. Lett. 48: 237-276.